Literature DB >> 23652733

Trends in vascular risk factor treatment and control in US stroke survivors: the National Health and Nutrition Examination Surveys (1999-2010).

Nilay S Shah1, Mark D Huffman, Hongyan Ning, Donald M Lloyd-Jones.   

Abstract

BACKGROUND: Treatment and control of vascular risk factors reduce the likelihood of recurrent stroke. Present nationally representative data are sparse regarding secondary prevention treatment and control rates. METHODS AND
RESULTS: We evaluated sex- and race-stratified blood pressure, cholesterol, and hemoglobin A1c levels and treatment and control rates in 1154 self-reported stroke survivors from the National Health and Nutrition Examination Surveys 1999 to 2010. We used weighted linear regression to estimate time trends. Participants were 54% to 61% women, 70% to 76% white, and had a mean age of 63 to 66 years. For blood pressure, treatment rates remained unchanged in men, but in women, treatment rates increased from 41% in 1999 to 2000 to 65% in 2009 to 2010 (P=0.03), and control rates increased from 23% to 79% (P=0.03). Treatment rates remained unchanged in non-Hispanic whites, non-Hispanic blacks, and Mexican Americans, although control rates increased in non-Hispanic whites from 50% in 1999 to 2002 to 69% in 2007 to 2010 (P=0.04). For cholesterol, treatment rates increased from 30% to 40% in men (P=0.02) and from 28% to 36% (P<0.01) in women, but control rates increased only in men, from 62% to 87% (P<0.01). Cholesterol treatment rates increased only in non-Hispanic blacks, from 18% to 37% (P=0.02). By sex and race, there was no change in dysglycemia treatment and control.
CONCLUSIONS: Despite improvements in blood pressure treatment and control and cholesterol treatment for women and cholesterol treatment and control for men, stroke secondary prevention through treatment and control of vascular risk factors remains suboptimal. Urgent action is needed to improve secondary prevention to reduce stroke morbidity and mortality in this high-risk group.

Entities:  

Keywords:  secondary prevention; stroke; treatment; trends

Mesh:

Substances:

Year:  2013        PMID: 23652733     DOI: 10.1161/CIRCOUTCOMES.113.000112

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  12 in total

1.  Lipid-Lowering Prescription Patterns in Patients With Diabetes Mellitus or Cardiovascular Disease.

Authors:  Alanna M Chamberlain; Sarah S Cohen; Jill M Killian; Keri L Monda; Susan A Weston; Ted Okerson
Journal:  Am J Cardiol       Date:  2019-07-15       Impact factor: 2.778

Review 2.  Resource Effective Strategies to Prevent and Treat Cardiovascular Disease.

Authors:  J D Schwalm; Martin McKee; Mark D Huffman; Salim Yusuf
Journal:  Circulation       Date:  2016-02-23       Impact factor: 29.690

3.  Trends in the incidence, treatment, and outcomes of acute lower extremity ischemia in the United States Medicare population.

Authors:  Donald T Baril; Kaushik Ghosh; Allison B Rosen
Journal:  J Vasc Surg       Date:  2014-04-24       Impact factor: 4.268

4.  Quantifying and addressing persistent stroke disparities in Hispanics.

Authors:  Jose G Romano; Ralph L Sacco
Journal:  Ann Neurol       Date:  2013-12       Impact factor: 10.422

Review 5.  Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology.

Authors:  Donald M Lloyd-Jones; Mark D Huffman; Kunal N Karmali; Darshak M Sanghavi; Janet S Wright; Colleen Pelser; Martha Gulati; Frederick A Masoudi; David C Goff
Journal:  Circulation       Date:  2016-11-04       Impact factor: 29.690

6.  Patterns and predictors of lipid-lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: Insights from a large US managed-care population.

Authors:  Dylan L Steen; Irfan Khan; Laura Becker; JoAnne M Foody; Katherine Gorcyca; Robert J Sanchez; Robert P Giugliano
Journal:  Clin Cardiol       Date:  2016-12-27       Impact factor: 2.882

7.  Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.

Authors:  Virginia J Howard; Rikki M Tanner; Aaron Anderson; Marguerite R Irvin; David A Calhoun; Daniel T Lackland; Suzanne Oparil; Paul Muntner
Journal:  Am J Med       Date:  2015-03-10       Impact factor: 4.965

8.  Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology.

Authors:  Donald M Lloyd-Jones; Mark D Huffman; Kunal N Karmali; Darshak M Sanghavi; Janet S Wright; Colleen Pelser; Martha Gulati; Frederick A Masoudi; David C Goff
Journal:  J Am Coll Cardiol       Date:  2016-11-04       Impact factor: 24.094

9.  Prevalence of Guideline-Directed Medical Therapy for Cardiovascular Disease Among Baltimore City Adults in the Healthy Aging in Neighborhoods of Diversity Across the Life Span (HANDLS) Study.

Authors:  Lena Mathews; Dingfen Han; Michele K Evans; Alan B Zonderman; Chiadi E Ndumele; Deidra C Crews
Journal:  J Racial Ethn Health Disparities       Date:  2021-02-16

10.  Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk.

Authors:  Adam Richards; Nicholas J Jackson; Eric M Cheng; Robert J Bryg; Arleen Brown; Amytis Towfighi; Nerses Sanossian; Frances Barry; Ning Li; Barbara G Vickrey
Journal:  Stroke       Date:  2020-03-23       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.